Citigroup’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-43
| Closed | -$508 | – | 5029 |
|
2022
Q4 | $508 | Sell |
43
-230
| -84% | -$2.72K | ﹤0.01% | 4713 |
|
2022
Q3 | $6K | Sell |
273
-346
| -56% | -$7.6K | ﹤0.01% | 4413 |
|
2022
Q2 | $15K | Sell |
619
-5,260
| -89% | -$127K | ﹤0.01% | 4459 |
|
2022
Q1 | $293K | Sell |
5,879
-15,848
| -73% | -$790K | ﹤0.01% | 3186 |
|
2021
Q4 | $1.53M | Buy |
21,727
+11,213
| +107% | +$787K | ﹤0.01% | 2177 |
|
2021
Q3 | $981K | Sell |
10,514
-19,095
| -64% | -$1.78M | ﹤0.01% | 2404 |
|
2021
Q2 | $2.98M | Sell |
29,609
-12,582
| -30% | -$1.26M | ﹤0.01% | 1815 |
|
2021
Q1 | $3.94M | Buy |
42,191
+40,637
| +2,615% | +$3.79M | ﹤0.01% | 1493 |
|
2020
Q4 | $129K | Buy |
1,554
+1,004
| +183% | +$83.3K | ﹤0.01% | 3515 |
|
2020
Q3 | $47K | Sell |
550
-329
| -37% | -$28.1K | ﹤0.01% | 3529 |
|
2020
Q2 | $82K | Sell |
879
-860
| -49% | -$80.2K | ﹤0.01% | 3571 |
|
2020
Q1 | $50K | Buy |
1,739
+457
| +36% | +$13.1K | ﹤0.01% | 3793 |
|
2019
Q4 | $53K | Buy |
1,282
+894
| +230% | +$37K | ﹤0.01% | 3926 |
|
2019
Q3 | $6K | Sell |
388
-645
| -62% | -$9.97K | ﹤0.01% | 4750 |
|
2019
Q2 | $36K | Buy |
1,033
+774
| +299% | +$27K | ﹤0.01% | 4304 |
|
2019
Q1 | $15K | Hold |
259
| – | – | ﹤0.01% | 4639 |
|
2018
Q4 | $12K | Sell |
259
-2
| -0.8% | -$93 | ﹤0.01% | 4583 |
|
2018
Q3 | $19K | Sell |
261
-8
| -3% | -$582 | ﹤0.01% | 4534 |
|
2018
Q2 | $22K | Sell |
269
-144
| -35% | -$11.8K | ﹤0.01% | 4347 |
|
2018
Q1 | $44K | Buy |
413
+115
| +39% | +$12.3K | ﹤0.01% | 3836 |
|
2017
Q4 | $39K | Buy |
298
+294
| +7,350% | +$38.5K | ﹤0.01% | 3926 |
|
2017
Q3 | $0 | Sell |
4
-1
| -20% | – | ﹤0.01% | 4904 |
|
2017
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 4770 |
|